Suppr超能文献

患有非胰岛素依赖型糖尿病的墨西哥裔美国人和非西班牙裔白人的蛋白尿

Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM.

作者信息

Haffner S M, Mitchell B D, Pugh J A, Stern M P, Kozlowski M K, Hazuda H P, Patterson J K, Klein R

机构信息

Department of Medicine, University of Texas Health Science Center, San Antonio, TX 78284.

出版信息

Diabetes Care. 1989 Sep;12(8):530-6. doi: 10.2337/diacare.12.8.530.

Abstract

Mexican Americans have a threefold greater prevalence of non-insulin-dependent diabetes mellitus (NIDDM) than non-Hispanic Whites as found in the San Antonio Heart Study, a population-based study of diabetes and cardiovascular disease. In addition, Mexican-American diabetic subjects have higher levels of glycemia than non-Hispanic White diabetic subjects. We therefore hypothesized that the prevalence of clinical proteinuria would be greater among Mexican-American diabetic subjects (n = 317) than among non-Hispanic White diabetic subjects (n = 67). Clinical proteinuria, defined as greater than or equal to 1+ on the Ames Albustix test, was 2.82 times more prevalent in Mexican-American diabetic subjects compared with non-Hispanic White diabetic subjects adjusting for age and duration (95% confidence interval [CI] = 1.05, 7.55; P = .039). After controlling for other possible confounding variables (i.e., glycemia, systolic blood pressure, smoking, and insulin use), the excess of proteinuria in Mexican-American diabetic subjects was only slightly attenuated, although the statistical significance became borderline (odds ratio [OR] = 2.59, 95% CI = 0.91, 7.32; P = .072). The prevalence of microalbuminuria (greater than 30 mg/L) was also significantly higher in Mexican-American diabetic subjects than in non-Hispanic White diabetic subjects (OR = 3.54, 95% CI = 1.28, 9.81; P = .015). We also compared previously diagnosed Mexican-American diabetic subjects (n = 243) from San Antonio with previously diagnosed non-Hispanic White diabetic subjects in Wisconsin (n = 476).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在一项基于人群的糖尿病和心血管疾病研究——圣安东尼奥心脏研究中发现,墨西哥裔美国人患非胰岛素依赖型糖尿病(NIDDM)的患病率是非西班牙裔白人的三倍。此外,墨西哥裔美国糖尿病患者的血糖水平高于非西班牙裔白人糖尿病患者。因此,我们推测,墨西哥裔美国糖尿病患者(n = 317)的临床蛋白尿患病率会高于非西班牙裔白人糖尿病患者(n = 67)。临床蛋白尿定义为艾姆斯尿蛋白试纸测试结果大于或等于1+,在调整年龄和病程后,墨西哥裔美国糖尿病患者的临床蛋白尿患病率是非西班牙裔白人糖尿病患者的2.82倍(95%置信区间[CI] = 1.05, 7.55;P = .039)。在控制了其他可能的混杂变量(即血糖、收缩压、吸烟和胰岛素使用情况)后,墨西哥裔美国糖尿病患者蛋白尿过多的情况仅略有缓解,尽管统计学意义已接近临界值(优势比[OR] = 2.59, 95% CI = 0.91, 7.32;P = .072)。微量白蛋白尿(大于30 mg/L)的患病率在墨西哥裔美国糖尿病患者中也显著高于非西班牙裔白人糖尿病患者(OR = 3.54, 95% CI = 1.28, 9.81;P = .015)。我们还将来自圣安东尼奥的先前确诊的墨西哥裔美国糖尿病患者(n = 243)与威斯康星州先前确诊的非西班牙裔白人糖尿病患者(n = 476)进行了比较。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验